CCA
Catalyst Capital Advisors’s Takeda Pharmaceutical TAK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.8M | Hold |
181,000
| – | – | 0.06% | 96 |
|
|
2025
Q1 | $2.69M | Buy |
181,000
+3,000
| +2% | +$44.6K | 0.06% | 97 |
|
|
2024
Q4 | $2.36M | Hold |
178,000
| – | – | 0.05% | 103 |
|
|
2024
Q3 | $2.53M | Buy |
178,000
+12,000
| +7% | +$171K | 0.06% | 102 |
|
|
2024
Q2 | $2.15M | Sell |
166,000
-3,000
| -2% | -$38.8K | 0.05% | 108 |
|
|
2024
Q1 | $2.35M | Hold |
169,000
| – | – | 0.06% | 108 |
|
|
2023
Q4 | $2.41M | Buy |
+169,000
| New | +$2.41M | 0.06% | 102 |
|
|
2021
Q4 | – | Sell |
-126,000
| Closed | -$2.06M | – | 423 |
|
|
2021
Q3 | $2.06M | Hold |
126,000
| – | – | 0.1% | 139 |
|
|
2021
Q2 | $2.12M | Buy |
126,000
+13,700
| +12% | +$231K | 0.1% | 127 |
|
|
2021
Q1 | $2.05M | Buy |
112,300
+24,000
| +27% | +$438K | 0.11% | 109 |
|
|
2020
Q4 | $1.61M | Buy |
88,300
+10,300
| +13% | +$187K | 0.09% | 121 |
|
|
2020
Q3 | $1.39M | Buy |
78,000
+40,000
| +105% | +$714K | 0.08% | 124 |
|
|
2020
Q2 | $681K | Buy |
+38,000
| New | +$681K | 0.04% | 160 |
|
|
2019
Q4 | – | Sell |
-5,215
| Closed | -$90K | – | 407 |
|
|
2019
Q3 | $90K | Buy |
5,215
+1,656
| +47% | +$28.6K | ﹤0.01% | 236 |
|
|
2019
Q2 | $63K | Sell |
3,559
-963
| -21% | -$17K | ﹤0.01% | 214 |
|
|
2019
Q1 | $92K | Buy |
+4,522
| New | +$92K | ﹤0.01% | 216 |
|